These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33095437)

  • 1. The Chronic Treatment With 5-HT
    Tsybko AS; Ilchibaeva TV; Filimonova EA; Eremin DV; Popova NK; Naumenko VS
    Neurochem Res; 2020 Dec; 45(12):3059-3075. PubMed ID: 33095437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
    Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
    Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute serotonin 2A receptor activation impairs behavioral flexibility in mice.
    Amodeo DA; Hassan O; Klein L; Halberstadt AL; Powell SB
    Behav Brain Res; 2020 Oct; 395():112861. PubMed ID: 32814148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of
    Jensen AA; McCorvy JD; Leth-Petersen S; Bundgaard C; Liebscher G; Kenakin TP; Bräuner-Osborne H; Kehler J; Kristensen JL
    J Pharmacol Exp Ther; 2017 Jun; 361(3):441-453. PubMed ID: 28360333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selective 5-HT
    Jensen AA; Halberstadt AL; Märcher-Rørsted E; Odland AU; Chatha M; Speth N; Liebscher G; Hansen M; Bräuner-Osborne H; Palner M; Andreasen JT; Kristensen JL
    Biochem Pharmacol; 2020 Jul; 177():113979. PubMed ID: 32298690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.
    Fantegrossi WE; Gray BW; Bailey JM; Smith DA; Hansen M; Kristensen JL
    Psychopharmacology (Berl); 2015 Mar; 232(6):1039-47. PubMed ID: 25224567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor β deficiency impairs BDNF-5-HT
    Chhibber A; Woody SK; Karim Rumi MA; Soares MJ; Zhao L
    Psychoneuroendocrinology; 2017 Aug; 82():107-116. PubMed ID: 28544903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.
    Hagsäter SM; Pettersson R; Pettersson C; Atanasovski D; Näslund J; Eriksson E
    Int J Neuropsychopharmacol; 2021 Sep; 24(9):749-757. PubMed ID: 34228806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a hallucinogenic serotonin 5-HT
    Zhang G; Cinalli D; Stackman RW
    Hippocampus; 2017 May; 27(5):558-569. PubMed ID: 28176400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically defined fear-induced aggression: Focus on BDNF and its receptors.
    Ilchibaeva TV; Tsybko AS; Kozhemyakina RV; Kondaurova EM; Popova NK; Naumenko VS
    Behav Brain Res; 2018 May; 343():102-110. PubMed ID: 29425916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 25CN-NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor.
    Märcher Rørsted E; Jensen AA; Kristensen JL
    ChemMedChem; 2021 Nov; 16(21):3263-3270. PubMed ID: 34288515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT
    Gao J; Chen L; Li M
    Pharmacol Biochem Behav; 2019 May; 180():32-43. PubMed ID: 30904543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective 5-HT2A receptor agonist 25CN-NBOH does not affect reversal learning in mice.
    Odland AU; Kristensen JL; Andreasen JT
    Behav Pharmacol; 2021 Aug; 32(5):448-452. PubMed ID: 33595957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.
    Takaba R; Ibi D; Yoshida K; Hosomi E; Kawase R; Kitagawa H; Goto H; Achiwa M; Mizutani K; Maeda K; González-Maeso J; Kitagaki S; Hiramatsu M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3019-3035. PubMed ID: 37874338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation.
    Odland AU; Jessen L; Kristensen JL; Fitzpatrick CM; Andreasen JT
    Neuropharmacology; 2021 Feb; 183():107838. PubMed ID: 31693871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative method for the selective 5-HT2A agonist 25CN-NBOH in rat plasma and brain.
    Breusova K; Ernstsen KG; Palner M; Linnet K; Kristensen JL; Kretschmann AC
    J Pharm Biomed Anal; 2021 May; 199():114016. PubMed ID: 33784574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in Streptozotocin-induced memory deficits in male rats.
    Afshar S; Shahidi S; Rohani AH; Komaki A; Asl SS
    Psychopharmacology (Berl); 2018 Oct; 235(10):2809-2822. PubMed ID: 30027497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF-TrkB/proBDNF-p75
    Jia D; Wang F; Bai Z; Chen X
    Sci Rep; 2023 Oct; 13(1):18364. PubMed ID: 37884604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Downregulation of p75
    Suelves N; Miguez A; López-Benito S; Barriga GG; Giralt A; Alvarez-Periel E; Arévalo JC; Alberch J; Ginés S; Brito V
    Mol Neurobiol; 2019 Feb; 56(2):935-953. PubMed ID: 29804232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.